erythrosine has been researched along with Macular Edema in 17 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa." | 9.08 | The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. ( Engler, C; Larsen, M; Li, B; Lund-Andersen, H; Moldow, B; Rosenberg, T; Sander, B, 1998) |
| " Gradings of baseline stereoscopic fluorescein angiograms of these eyes were used to examine relationships of angiographic characteristics with each other, with retinopathy severity level and macular edema status graded from color photographs, and with risk of progression from nonproliferative to proliferative retinopathy during 1 to 5 years of follow-up." | 9.07 | Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group. ( , 1991) |
| "To detect cystoid macular edema after extracapsular cataract extraction, the authors used indirect ophthalmoscopy after oral application of fluorescein, rather than intravenous fluorescein angiography." | 7.67 | [Detection of cystoid macular edema with orally administered fluorescein]. ( Hessemer, V; Hütz, W; Jacobi, KW, 1989) |
| "The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa." | 5.08 | The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. ( Engler, C; Larsen, M; Li, B; Lund-Andersen, H; Moldow, B; Rosenberg, T; Sander, B, 1998) |
| " Gradings of baseline stereoscopic fluorescein angiograms of these eyes were used to examine relationships of angiographic characteristics with each other, with retinopathy severity level and macular edema status graded from color photographs, and with risk of progression from nonproliferative to proliferative retinopathy during 1 to 5 years of follow-up." | 5.07 | Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group. ( , 1991) |
| "By application of the standard ex vivo pimonidazole-adduct immunostaining technique, retinal hypoxia was observed within 2 hours post-PRVT." | 3.85 | In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO). ( Jayagopal, A; McCollum, GW; Penn, JS; Uddin, MI; Yang, R, 2017) |
| "To detect cystoid macular edema after extracapsular cataract extraction, the authors used indirect ophthalmoscopy after oral application of fluorescein, rather than intravenous fluorescein angiography." | 3.67 | [Detection of cystoid macular edema with orally administered fluorescein]. ( Hessemer, V; Hütz, W; Jacobi, KW, 1989) |
| "This study aimed at investigating the clinical effect of ranibizumab combined with panretinal photocoagulation in the treatment of macular edema in diabetic retinopathy (DR) patients." | 1.72 | Optical Coherence Tomography Combined with Fluorescein Fundus Angiography under Intelligent Algorithm to Evaluate the Clinical Efficacy of Ranibizumab Combined with Panretinal Photocoagulation in the Treatment of Macular Edema of Diabetic Retinopathy Pati ( Huang, J; Li, L; Zhou, Q, 2022) |
| "This possibly reduces the incidence of cystoid macular edema (diffusion of prostaglandins), retinal detachment (loss of hyaluronic acid of the vitreous), endophthalmitis (spread of bacteria) or rubeosis iridis (angiogenic factor) after YAG capsulotomy." | 1.29 | [The aqueous humor-vitreous body barrier and the blood-aqueous humor barrier after YAG laser capsulotomy in capsular sac vs ciliary sulcus fixation of the intraocular lens]. ( Magone, T; Ohrloff, C; Schalnus, RW, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Zhou, Q | 1 |
| Huang, J | 1 |
| Foos, WF | 1 |
| Culp, C | 1 |
| Asahi, M | 1 |
| Patronas, M | 1 |
| Uddin, MI | 1 |
| Jayagopal, A | 1 |
| McCollum, GW | 1 |
| Yang, R | 1 |
| Penn, JS | 1 |
| Chen, X | 1 |
| Mangalesh, S | 1 |
| Tran-Viet, D | 1 |
| Freedman, SF | 1 |
| Vajzovic, L | 1 |
| Toth, CA | 1 |
| Noble, MJ | 1 |
| Cheng, H | 1 |
| Jacobs, PM | 1 |
| Schalnus, RW | 1 |
| Ohrloff, C | 1 |
| Magone, T | 1 |
| Moldow, B | 1 |
| Sander, B | 1 |
| Larsen, M | 1 |
| Engler, C | 1 |
| Li, B | 1 |
| Rosenberg, T | 1 |
| Lund-Andersen, H | 1 |
| Ferris, FL | 1 |
| Hütz, W | 1 |
| Hessemer, V | 1 |
| Jacobi, KW | 1 |
| Miyake, K | 2 |
| Fontana, M | 1 |
| Verriest, G | 1 |
| Schauwvlieghe, P | 2 |
| De Laey, JJ | 2 |
| Gray, JR | 1 |
| Mosier, MA | 1 |
| Ishimoto, BM | 1 |
| Quentel, G | 1 |
| Zerah, I | 1 |
| Coscas, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care (BabySTEPS)[NCT02887157] | 191 participants (Actual) | Observational | 2016-07-22 | Completed | |||
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study (BabySTEPS2)[NCT04995341] | 236 participants (Anticipated) | Interventional | 2021-08-16 | Recruiting | |||
| [NCT00000151] | Phase 3 | 0 participants | Interventional | 1979-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for erythrosine and Macular Edema
| Article | Year |
|---|---|
Fluorophotometric evaluation of the blood-ocular barrier function following cataract surgery and intraocular lens implantation.
Topics: Anterior Chamber; Aphakia, Postcataract; Biological Transport; Cataract Extraction; Eye; Fluorescein | 1988 |
2 trials available for erythrosine and Macular Edema
| Article | Year |
|---|---|
The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Topics: Acetazolamide; Adult; Biological Transport, Active; Blood-Retinal Barrier; Carbonic Anhydrase Inhibi | 1998 |
Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adolescent; Adult; Aged; Aspirin; Diabetic Retinopathy; Female; Fluorescein; Fluorescein Angiography | 1991 |
14 other studies available for erythrosine and Macular Edema
| Article | Year |
|---|---|
Optical Coherence Tomography Combined with Fluorescein Fundus Angiography under Intelligent Algorithm to Evaluate the Clinical Efficacy of Ranibizumab Combined with Panretinal Photocoagulation in the Treatment of Macular Edema of Diabetic Retinopathy Pati
Topics: Algorithms; Angiogenesis Inhibitors; Angiography; Diabetes Mellitus; Diabetic Retinopathy; Fluoresce | 2022 |
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Ede | 2022 |
In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO).
Topics: Animals; Disease Models, Animal; Fluorescein Angiography; Fluoresceins; Fluorescent Dyes; Hypoxia; I | 2017 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Oral fluorescein and cystoid macular oedema: detection in aphakic and pseudophakic eyes.
Topics: Cataract Extraction; Fluorescein Angiography; Fluoresceins; Humans; Lenses, Intraocular; Macular Ede | 1984 |
[The aqueous humor-vitreous body barrier and the blood-aqueous humor barrier after YAG laser capsulotomy in capsular sac vs ciliary sulcus fixation of the intraocular lens].
Topics: Aqueous Humor; Blood-Retinal Barrier; Capillary Permeability; Diffusion; Fluorescein; Fluoresceins; | 1995 |
Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.
Topics: Adult; Diabetic Retinopathy; Fluorescein; Fluoresceins; Humans; Light Coagulation; Macular Edema; Ma | 1991 |
[Detection of cystoid macular edema with orally administered fluorescein].
Topics: Administration, Oral; Female; Fluorescein; Fluorescein Angiography; Fluoresceins; Humans; Lenses, In | 1989 |
Modification by fluoangiography of color vision in diabetic patients.
Topics: Biomechanical Phenomena; Color Vision Defects; Diabetic Retinopathy; Fluorescein; Fluorescein Angiog | 1986 |
Fluorophotometry. Indications and technique.
Topics: Aged; Diabetic Retinopathy; Eye Diseases; Fluoresceins; Fluorometry; Humans; Image Interpretation, C | 1985 |
Fluorophotometry in retinitis pigmentosa.
Topics: Adult; Blood-Retinal Barrier; Female; Fluoresceins; Fluorometry; Humans; Macular Edema; Male; Middle | 1985 |
Optimized protocol for Fluorotron Master.
Topics: Adult; Ciliary Body; Diabetes Mellitus; Fluorescein; Fluoresceins; Humans; Hypertension; Macular Ede | 1985 |
Vitreous fluorophotometry studies in aphakia.
Topics: Aged; Aphakia, Postcataract; Edema; Female; Fluorescein; Fluoresceins; Humans; Macula Lutea; Macular | 1985 |
Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema.
Topics: Aged; Aphakia, Postcataract; Cataract Extraction; Chronic Disease; Female; Fluorescein; Fluoresceins | 1985 |